ClinicalTrials.Veeva

Menu

Influence of Handedness on Upper Limb Recovery (HANDISTROKE)

C

Centre Hospitalier Régional d'Orléans

Status

Begins enrollment this month

Conditions

Stroke

Treatments

Other: evaluation

Study type

Observational

Funder types

Other

Identifiers

NCT07357181
CHUO-2025-19

Details and patient eligibility

About

This prospective, single-center observational study evaluates whether handedness is associated with upper-limb motor recovery after a recent unilateral stroke. Adults admitted to the stroke unit with a confirmed unilateral stroke within 5 days are included if they do not object to participation. Upper-limb impairment is assessed early after stroke and at 6 months using standardized clinical scales. Handedness is determined by self-report, and the Edinburgh Handedness Inventory is administered when feasible. The main hypothesis is that left-handed participants may show better upper-limb motor recovery at 6 months than right-handed participants, potentially due to differences in brain motor network lateralization.

Full description

Participants hospitalized in the stroke unit with a confirmed unilateral stroke are recruited consecutively. After eligibility verification and absence of objection, baseline data are collected within 5 days post-stroke. Baseline assessments include the Fugl-Meyer Assessment for the Upper Extremity (FMA-UE), the Shoulder Abduction and Finger Extension (SAFE) score, and the National Institutes of Health Stroke Scale (NIHSS) score (post-acute treatment if thrombolysis or thrombectomy was performed). Handedness is recorded after the motor assessments to maintain assessor blinding regarding group membership; the Edinburgh Handedness Inventory is administered when cognitive status allows. A 6-month follow-up is performed during routine post-stroke consultation at the study site, with repeat FMA-UE and SAFE assessments. The primary analysis compares FMA-UE at 6 months between left-handed and right-handed participants among those with baseline FMA-UE less than 66, using propensity score matching (3:1 right-handed to left-handed) accounting for age, baseline motor deficit, lesion side relative to dominance (dominant vs non-dominant hemisphere), and stroke type (ischemic vs hemorrhagic).

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Confirmed unilateral recent stroke (less than 5 days).
  2. Age 18 years and older.
  3. Participant or proxy does not object to participation

Exclusion criteria

  1. Prior stroke with residual motor sequelae.
  2. Pre-stroke upper-limb deficit.
  3. Follow-up at 6 months not planned at Orléans.
  4. Protected adult (guardianship/curatorship), person under legal protection, or deprived of liberty.
  5. Pregnant or breastfeeding woman.

Trial design

500 participants in 1 patient group

Patients with confirmed unilateral recent stroke
Treatment:
Other: evaluation

Trial contacts and locations

1

Loading...

Central trial contact

Julien BONNAL, MK

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems